142 related articles for article (PubMed ID: 9009658)
1. A new pharmaceutical concept for the treatment of oropharyngeal and oesophageal candidosis with fluconazole.
Wildfeuer A; Laufen H; Yeates RA; Zimmermann T
Mycoses; 1996; 39(9-10):357-60. PubMed ID: 9009658
[TBL] [Abstract][Full Text] [Related]
2. [A new pharmaceutical concept for the therapy of oropharyngeal and esophageal candidiasis with fluconazole].
Wildfeuer A; Laufen H; Yeates RA; Zimmermann T
Mycoses; 1996; 39 Suppl 1():123-6. PubMed ID: 8767284
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic optimization of the treatment of oral candidiasis with fluconazole: studies with a suspension.
Laufen H; Yeates RA; Zimmermann T; de los Reyes C
Drugs Exp Clin Res; 1995; 21(1):23-8. PubMed ID: 7796709
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of fluconazole in saliva and plasma after administration of an oral suspension and capsules.
Koks CH; Meenhorst PL; Hillebrand MJ; Bult A; Beijnen JH
Antimicrob Agents Chemother; 1996 Aug; 40(8):1935-7. PubMed ID: 8843308
[TBL] [Abstract][Full Text] [Related]
5. Prospective study of fluconazole suspension for the treatment of oesophageal candidiasis in patients with AIDS.
Laine L; Rabeneck L
Aliment Pharmacol Ther; 1995 Oct; 9(5):553-6. PubMed ID: 8580277
[TBL] [Abstract][Full Text] [Related]
6. A comparison of fluconazole oral suspension and amphotericin B oral suspension in older patients with oropharyngeal candidosis. Multicentre Study Group.
Taillandier J; Esnault Y; Alemanni M
Age Ageing; 2000 Mar; 29(2):117-23. PubMed ID: 10791445
[TBL] [Abstract][Full Text] [Related]
7. Can fluconazole concentrations in saliva be used for therapeutic drug monitoring?
Koks CH; Crommentuyn KM; Hoetelmans RM; Mathôt RA; Beijnen JH
Ther Drug Monit; 2001 Aug; 23(4):449-53. PubMed ID: 11477332
[TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses.
Debruyne D
Clin Pharmacokinet; 1997 Jul; 33(1):52-77. PubMed ID: 9250423
[TBL] [Abstract][Full Text] [Related]
9. Fluconazole versus nystatin in the treatment of oral candidosis.
Blomgren J; Berggren U; Jontell M
Acta Odontol Scand; 1998 Aug; 56(4):202-5. PubMed ID: 9765010
[TBL] [Abstract][Full Text] [Related]
10. Fluconazole for the treatment of candidiasis: 15 years experience.
Cha R; Sobel JD
Expert Rev Anti Infect Ther; 2004 Jun; 2(3):357-66. PubMed ID: 15482201
[TBL] [Abstract][Full Text] [Related]
11. Fluconazole suspension for oropharyngeal candidiasis unresponsive to tablets.
Martins MD; Rex JH
Ann Intern Med; 1997 Feb; 126(4):332-3. PubMed ID: 9036812
[No Abstract] [Full Text] [Related]
12. Comparative bioavailability of two fluconazole capsule formulations in healthy volunteers.
Ribeiro W; Zappi EA; Moraes ME; Bezerra FA; Lerner FE; de Nucci G
Arzneimittelforschung; 2000 Nov; 50(11):1028-32. PubMed ID: 11148859
[TBL] [Abstract][Full Text] [Related]
13. [Use of fluconazole in children less than 1 year old: review].
Schwarze R; Penk A; Pittrow L
Mycoses; 1998; 41 Suppl 1():61-70. PubMed ID: 9717389
[TBL] [Abstract][Full Text] [Related]
14. Oropharyngeal candidiasis in patients with AIDS: randomized comparison of fluconazole versus nystatin oral suspensions.
Pons V; Greenspan D; Lozada-Nur F; McPhail L; Gallant JE; Tunkel A; Johnson CC; McCarty J; Panzer H; Levenstein M; Barranco A; Green S
Clin Infect Dis; 1997 Jun; 24(6):1204-7. PubMed ID: 9195083
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and tolerance of fluconazole suppositories in healthy volunteers.
Pfaff G; Zimmermann T; Lach P; Yeates R; Simon G; Wildfeuer A
Arzneimittelforschung; 1993 Mar; 43(3):391-5. PubMed ID: 8489572
[TBL] [Abstract][Full Text] [Related]
16. Fluconazole concentrations in saliva from AIDS patients with oropharyngeal candidosis refractory to treatment with fluconazole.
Garcia-Hermoso D; Dromer F; Improvisi L; Provost F; Dupont B
Antimicrob Agents Chemother; 1995 Mar; 39(3):656-60. PubMed ID: 7793868
[TBL] [Abstract][Full Text] [Related]
17. Fluconazole bioequivalence study: quantification by tandem mass spectrometry.
Moraes LA; Lerner FE; Moraes ME; Moraes MO; Corso G; De Nucci G
Ther Drug Monit; 1999 Apr; 21(2):200-7. PubMed ID: 10217340
[TBL] [Abstract][Full Text] [Related]
18. Administration of fluconazole in children below 1 year of age.
Schwarze R; Penk A; Pittrow L
Mycoses; 1999 Apr; 42(1-2):3-16. PubMed ID: 10394841
[TBL] [Abstract][Full Text] [Related]
19. Salivary concentrations of ketoconazole and fluconazole: implications for drug efficacy in oropharyngeal and esophageal candidiasis.
Force RW; Nahata MC
Ann Pharmacother; 1995 Jan; 29(1):10-5. PubMed ID: 7711339
[TBL] [Abstract][Full Text] [Related]
20. [Itraconazole suspension in the treatment of HIV-infected patients with fluconazole-resistant oropharyngeal candidiasis and esophagitis].
Eichel M; Just-Nübling G; Helm EB; Stille W
Mycoses; 1996; 39 Suppl 1():102-6. PubMed ID: 8767280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
